Post Job

MaxCyte overview

Industry
Biotechnology
Revenue
Headquarters
Employees
65
Founded In
Website
Organization Type
Public
Social Media
MaxCyte, Inc. specializes in cell modification technologies that enable the discovery, development, and manufacture of various classes of therapeutics for a range of chronic and acute diseases. It provides MaxCyte STX, a scalable transfection system for the scalable and reagent-free (co) transfection of primary cells, stem cells, and cell lines involved in the areas of cell-based assays for content screening, preclinical protein production, and small molecule drug discovery.MaxCyte, Inc. was formerly known as TheraMed, Inc. and changed its name to MaxCyte, Inc. in October 2001. The company was founded in 1999 and is based in Gaithersburg, Maryland.
Based in Gaithersburg, MD, MaxCyte is a small health care company with only 65 employees and an annual revenue of $44.0M.

MaxCyte's Mission Statement

To enable the engineering of nearly all cell types, including human primary cells and cells for biomanufacturing, with any molecule, at any scale.

-

MaxCyte employee reviews

Be the first to review!

Do you work at MaxCyte?

Help job seekers learn about working at MaxCyte

On This Page

Be The First To Review MaxCyte

Anonymously rate your employee experience

Your Opinion can Help Other Job Seekers

Do You Like Working At MaxCyte?

The team at MaxCyte

  • The founders of MaxCyte is John Holaday.
  • The key people at MaxCyte are Douglas A. Doerfler and John Holaday.
Key People
Douglas A. Doerfler
John Holaday

MaxCyte Rankings

MaxCyte is ranked #19 on the Best Health Care Companies to Work For in Maryland list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate MaxCyte's commitment to diversity and inclusion.

Zippia waving zebra

Do you work at MaxCyte?

Is MaxCyte's workforce diverse and inclusive?

MaxCyte Financial Performance

9.5
Performance Score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

MaxCyte currently has 44.3M in revenue. MaxCyte's most recent quarter produced 9.0m (q2'2023).

MaxCyte annual revenue

$44M
$35M
$27M
$18M
$9M
$0
2020
2021
2022

Are You An Executive, HR Leader, Or Brand Manager At MaxCyte?

Claiming and updating your company profile on Zippia is free and easy.

MaxCyte FAQs

Search for jobs

Zippia gives an in-depth look into the details of MaxCyte, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MaxCyte. The employee data is based on information from people who have self-reported their past or current employments at MaxCyte. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MaxCyte. The data presented on this page does not represent the view of MaxCyte and its employees or that of Zippia.

MaxCyte may also be known as or be related to MAXCYTE INC., MAXCYTE, INC., MaxCyte, MaxCyte Inc, MaxCyte Inc., MaxCyte, Inc. and Maxcyte, Inc.